Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26F7MAF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,716
Award facts
- Contract value 100% obligated
- $13,716.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on November 17, 2025, for $13,716.46 to supply Dupixent 300 mg/2 mL pens (2 mL), a prescription medication used to treat eczema, asthma, and other inflammatory conditions. This non-competitive, firm fixed-price delivery order is expected to be completed by November 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement across the Department of Defense, the Defense Health Agency, and other government healthcare systems. The company has demonstrated substantial capacity to fulfill federal pharmaceutical supply requirements through its extensive portfolio of competitive contract awards with DLA, consistently delivering brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order represents a routine procurement from the company's prime vendor contract, which enables DLA to efficiently source pharmaceutical products for military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F7MAF?
SPE2DR26F7MAF was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26F7MAF worth?
The government has obligated $13,716 on SPE2DR26F7MAF.
Is contract SPE2DR26F7MAF an order under another contract?
Yes. SPE2DR26F7MAF is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7MAF competed?
The extent of competition for SPE2DR26F7MAF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award